HIST1H4L was significantly upregulated in SCLC tumors versus normal tissues and enriched in DNA transcription-related pathways and correlated with poor patient survival; critically, high HIST1H4L expression correlated with poor patient survival.
Abstract
Objective Despite advances in treatment, small cell lung cancer (SCLC) remains highly aggressive and prone to relapse, leading to poor patient outcomes. Histone HIST1H4L is a key protein that maintains chromatin structure, but its role in SCLC is still unclear. This study aims to define its oncogenic role in SCLC and to determine whether it drives malignant progression by activating the PI3K/AKT signaling pathway. Materials and methods Public datasets were used to integrate HIST1H4L expression with differentially expressed genes. Functional bioinformatics investigations and survival association analyses were then conducted. Additionally, stable HIST1H4L knockdown cell lines were generated. Knockdown efficiency was confirmed at the mRNA and protein levels by qRT-PCR and Western blot (WB). Cell proliferation was measured using CCK-8 and EdU staining. Cell invasion was assessed with Transwell assays. Cellular senescence and apoptosis were evaluated by β-galactosidase staining and flow cytometry, respectively. Finally, WB was used to detect changes in key proteins of the PI3K/AKT signaling pathway after HIST1H4L knockdown. Results HIST1H4L was significantly upregulated in SCLC tumors versus normal tissues and enriched in DNA transcription-related pathways. Critically, high HIST1H4L expression correlated with poor patient survival. HIST1H4L knockdown markedly suppressed proliferation, migration, and invasion. It also reduced senescence and apoptosis. HIST1H4L knockdown weakened the activation of the PI3K/AKT signaling pathway. The levels of p-AKT and p-PI3K decreased, while total AKT and PI3K levels remained unchanged. Conclusion HIST1H4L is significantly overexpressed in SCLC and correlates with poor prognosis. It functions as a key oncogenic driver by activating the PI3K/AKT pathway, promoting tumor proliferation and invasion.
Lung squamous cell carcinoma (LUSC) is an aggressive malignancy with a poor prognosis. Given the association between mitochondrial dysregulation and LUSC, the aim of the present study was to identify mitochondrial unfolded protein response (UPRmt)-related candidate genes associated with LUSC and to explore their potent...
Clinically, these findings identify the METTL1/USP48/LCN2 pathway as a potential therapeutic target for cSCC and elucidated a novel oncogenic axis in cSCC, wherein METTL1 stabilized USP48 mRNA through m7G methylation modification, and USP48 in turn deubiquitinated and stabilized LCN2 protein.
Xiu-Qi Li, Lin Shu, Xiao-Qiang Li et al.· Applied Biochemistry and Bio...· 0 citations
Experimental data indicated that P4HA3 facilitated GC cell proliferation, migration and invasion, and enhanced glycolytic activity and increased the expression of key glycolysis-related proteins, suggesting that P4HA3 may induce a broader metabolic activation rather than an exclusively glycolytic shift.
Tao Wang, Xiao Xu, C. Jin et al.· Pakistan Journal of Pharmace...· 0 citations
It is demonstrated that EZH2 promotes NSCLC progression through activation of the JAK2/STAT3 signaling pathway, identifying the EZH2-JAK2/STAT3 axis as a potential therapeutic vulnerability in this malignancy.
SGPP1 functions as a tumor suppressor gene in ESCC and may inhibit tumor progression by regulating UGT1A9/UGT2B28‑mediated metabolic pathways and serve as a prognostic biomarker and a potential therapeutic target in ESCC.
L. Su, L. Hou, Xue-Tao Han et al.· Oncology Report· 0 citations